Member Login
  1. Stocks
    2. /
  2. Canopy Growth (TSX: WEED)
    3. /

TSX:WEED (Canopy Growth)

About WEED

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Canopy Growth (TSX: WEED) Latest News

    Investing in Retail Stocks In Canada
    Page

    Top Canadian Retail Stocks of 2025

    | Iain Butler

    When it comes to major sectors in the Canadian stock market, most investors think of the top three: energy, materials,…

    Read more »

    Tech Stocks

    The 3 Best Canadian Stocks to Buy and Hold

    | Amy Legate-Wolfe

    It can be hard to consider stocks with a high share price, but these are the best Canadian stocks to…

    Read more »

    Tech Stocks

    4 Canadian Stocks That Could Deliver Multi-Fold Returns Over the Next 10 Years

    | Rajiv Nanjapla

    Given the favourable industry trend and their growth initiatives, these four Canadian stocks could deliver multi-fold returns over the next…

    Read more »

    Cannabis Stocks

    1 Key Catalyst That Could Cause Cannabis Stocks to Implode This Year

    | Chris MacDonald

    For those interested in investing in cannabis stocks, it's important to consider the strength of the catalysts one is betting…

    Read more »

    Tech Stocks

    2 Canadian Stocks Primed for a Short Squeeze in July

    | Adam Othman

    If you have the right "trader" instinct and tolerance for high-risk, high-reward investments, leveraging a short squeeze might be the…

    Read more »

    Cannabis Stocks

    Down 60% From Record Highs, Is Canopy Growth Stock a Buy?

    | Aditya Raghunath

    Canopy Growth is a cannabis company that has underperformed the markets in the last two years. Is it a contrarian…

    Read more »

    Cannabis Stocks

    Why Canopy Growth Stock May Be in for Some Downside Pressure From Here

    | Chris MacDonald

    Here's why more downside may be on the horizon for Canopy Growth Corp. (TSX:WEED)(NYSE:CGC).

    Read more »

    Cannabis Stocks

    Earnings Miss Has Canopy Growth on the Outside Looking in

    | Chris MacDonald

    Should investors buy Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) on the dip or heed the warnings the market is putting out today?

    Read more »

    Cannabis Stocks

    Canopy Growth Drops Drake: Is it the Trendy Stock it Once Was?

    | Chris MacDonald

    What should investors make of the recent dissolution of the dissolution of Drake's partnership with Canopy Growth (TSX:WEED)(NYSE:CGC)?

    Read more »

    Energy Stocks

    Got $1,000? Buy These 4 Cheap Canadian Stocks Right Now

    | Rajiv Nanjapla

    These four Canadian stocks can deliver superior returns this year, given their high-growth prospects and attractive valuation.

    Read more »

    Cannabis Stocks

    Canopy (TSX:WEED) and Drake Break Up: Why the Deal Went up in Smoke

    | Adam Othman

    Canopy's history of partnership with celebrities is far from stellar, and it recently ended another partnership venture with Drake.

    Read more »

    Investing

    2 Marijuana Stocks to Consider Before U.S. Legalization

    | Adam Othman

    Marijuana legalization in the U.S. seems right around the corner, potentially giving U.S.-facing Canadian cannabis companies a powerful valuation boost.

    Read more »